2026 Global Pharmaceutical Exhibition 'CPHI' to be Held… What is the Future of Korea's Pharmaceutical and Bio Industry?
The world's largest pharmaceutical and bio industry exhibition, 'CPHI 2026,' is scheduled to be held soon. This event is expected to serve as a significant venue where major global pharmaceutical companies and contract development and manufacturing organization (CDMO) firms gather to share the latest technologies and industry trends.
Next-generation pharmaceutical production capabilities will be the core theme of this exhibition. In particular, new drug development utilizing artificial intelligence and technologies for the efficient production of complex-structured drugs will be introduced intensively. Many companies aim to increase production efficiency and strengthen their competitiveness in the global market through these advancements.
In addition, supply chain diversification and eco-friendly process technologies, which have recently gained importance, will also be discussed as key agendas. With the strengthening of global environmental regulations, pharmaceutical companies are seeking ways to reduce carbon emissions and produce drugs in a sustainable manner. Korean companies are also accelerating the adoption of eco-friendly technologies in line with these changes.
CPHI 2026 is an opportunity for Korean pharmaceutical and bio companies to prove their technological prowess in the global market. Experts expect this event to serve as a catalyst for Korean firms to expand global partnerships and take the lead in the future pharmaceutical industry.